persistent nasal carriage of Staphylococcus aureus is associated with deficient induction of human β-defensin 3 after sterile wounding of healthy skin in vivo

Infection and Immunity

Volumn 79, Issue 7, 2011, Pages 2658-2662

  Zanger, Philipp ^a   Nurjadi, Dennis ^a   Vath, Bernadette ^a   Kremsner, Peter G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 3; MESSENGER RNA; POLYPEPTIDE ANTIBIOTIC AGENT; RIBONUCLEASE; RIBONUCLEASE 7; UNCLASSIFIED DRUG;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; GLUTEUS MAXIMUS MUSCLE; HUMAN; IN VIVO STUDY; KERATINOCYTE; MALE; NOSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INJURY; SKIN PROTECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; BETA-DEFENSINS; CARRIER STATE; FEMALE; HUMANS; IMMUNITY, INNATE; MALE; NASAL CAVITY; NASAL MUCOSA; NOSE; RIBONUCLEASES; RNA, MESSENGER; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WOUND HEALING;

EID: 79959451998     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00101-11     Document Type: Article

References (29)

1. Asano, S., Y. Ichikawa, T. Kumagai, M. Kawashima, and G. Imokawa. 2008. Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis. Br. J. Dermatol. 159:97-104.
2. Cole, A. M., et al. 2001. Determinants of Staphylococcus aureus nasal carriage. Clin. Diagn. Lab. Immunol. 8:1064-1069.
3. Emonts, M., et al. 2008. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197:1244-1253.
4. Groth, M., et al. 2010. Both copy number and sequence variations affect expression of human DEFB4. Genes Immun. 11:458-466.
5. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 2001. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276:5707-5713.
6. Harder, J., et al. 2010. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J. Investig. Dermatol. 130:1355-1364.
7. Harder, J., and J. M. Schröder. 2002. RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J. Biol. Chem. 277: 46779-46784.
8. Howell, M. D., et al. 2006. Mechanism of HBD-3 deficiency in atopic dermatitis. Clin. Immunol. 121:332-338.
9. Kalus, A. A., et al. 2009. Association of a genetic polymorphism (_44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes. BMC Oral Health 9:21.
10. Kisich, K. O., C. W. Carspecken, S. Fieve, M. Boguniewicz, and D. Y. Leung. 2008. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. J. Allergy Clin. Immunol. 122:62-68.
11. Kisich, K. O., et al. 2007. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J. Investig. Dermatol. 127:2368-2380.
12. Menzies, B. E., and A. Kenoyer. 2006. Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human betadefensin 3 in skin keratinocytes. Infect. Immun. 74:6847-6854.
13. Nomura, I., et al. 2003. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171:3262-3269.
14. Nouwen, J. L., M. W. Fieren, S. Snijders, H. A. Verbrugh, and A. van Belkum. 2005. Persistent (not intermittent) nasal carriage of Staphylococcus aureus is the determinant of CPD-related infections. Kidney Int. 67:1084-1092.
15. Nouwen, J. L., et al. 2004. Predicting the Staphylococcus aureus nasal carrier state: derivation and validation of a "culture rule." Clin. Infect. Dis. 39:806-811.
16. Ong, P. Y., et al. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
17. Peacock, S. J., I. de Silva, and F. D. Lowy. 2001. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol. 9:605-610.
18. Reithmayer, K., et al. 2009. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br. J. Dermatol. 161:78-89.
19. Ruimy, R., et al. 2010. Are host genetics the predominant determinant of persistent nasal Staphylococcus aureus carriage in humans? J. Infect. Dis. 202:924-934.
20. Simanski, M., S. Dressel, R. Gläser, and J. Harder. 2010. RNase 7 protects healthy skin from Staphylococcus aureus colonization. J. Investig. Dermatol. 130:2836-2838.
21. Sørensen, O. E., et al. 2006. Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J. Clin. Invest. 116:1878-1885.
22. van Belkum, A., et al. 2007. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes Infect. 9:1471-1477.
23. van den Akker, E. L., et al. 2006. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J. Infect. Dis. 194:814-818.
24. VandenBergh, M. F., et al. 1999. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J. Clin. Microbiol. 37:3133-3140.
25. Wertheim, H. F., et al. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762.
26. White, A. 1961. Quantitative studies of nasal carriers of staphylococci among hospitalized patients. J. Clin. Invest. 40:23-30.
27. White, A., T. Hemmerly, M. P. Martin, and V. Knight. 1959. Studies on the origin of drug-resistant staphylococci in a mental hospital. Am. J. Med. 27:26-39.
28. Zanger, P., et al. 2010. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3 but not human beta-defensin 2. Infect. Immun. 78:3112-3117.
29. Zanger, P., et al. 2009. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J. Infect. Dis. 200:1907-1915.